資訊推薦

• 三、如第二題圖示之變頻器（Inverter）：【題組】 ⑴如採 120 度之方波切換機構，草繪 v ab 之波形、求 v ab 之基本波有效值、寫出v ab 之前四個諧波階數、此馬達之最低且最重要之抖
• 四、試說明何謂生物多樣性資訊學（Biodiversity informatics）？目前全球發展的狀況，及其與分類學間之關係。（15 分）
• 3 When the examiner inappropriately combined some components selected from the prior art to fit the
• 【題組】⑵常見的荷爾蒙治療藥品及標靶用藥請各舉一例。（20 分）
• 【題組】 ⑵Cryptic species
• 9 In the United States, even though the inventor was first to invent, he may be barred if he publicl
• 五、臺灣物種多樣性十分豐富，可謂「生物多樣性之島」，請問臺灣約有多少物種？造成其多樣性高之原因及機制為何？（15 分）
• 4 The preliminary injunction the plaintiff seeks in the case of patent infringement is an extraordin
• 五、請說明下列藥品可能因病人的基因型差異（genetic variation），而引起何種疾病或副作用？（每小題 4 分，共 20 分）【題組】⑴Angiotensin converting enzy
• 【題組】 ⑵請說明信心區間的意義。（6 分）
• 5 The ultimate aim of the TRIPS Agreement is to achieve the goal of harmonization over the substanti
• 【題組】 ⑵Carbamazepine / HLA-B*1502 allele
• 10 Which one of the following treaties has no relationship with the patent protection?(A) Paris Conv
• 6 The elements of patentability do not include which of the following:(A) novelty (B) utility (C) po
• 11 Which one of the following factors is most unlikely to be considered in a patent litigation in th
• 12 Which of the following reasons is not among the exceptions of the early publication of patent app
• 21 On claim drafting, a patent applicant sometimes uses a term in a manner leading to an either more
• 【題組】 ⑵如採正弦脈寬調制機構，其幅度調制指數為 m a = 0 . 8 、頻率調制指數為 m f = 75 、基本波頻率為 f1 = 50 Hz ，求： v ab 之基本波有效值、寫出 v ab
• 22 On determination of nonobviousness of a combination invention, the examiner is always concerned a
• 【題組】 ⑵此線性迴歸模型的估計標準差Sε為何？（5 分）
• 13 An invention patent application would be through the procedure of substantive examination prior t
• 【題組】 ⑵經耐震評估發現此街屋地面層於平行道路方向耐震能力不足，試規劃兩種可行之補強方案，並繪圖說明之。（10 分）空地鄰房 鄰房騎樓道路一層平面圖 二層平面圖 三層平面圖
• 23 _______ is an illustrative example of practice of an invention, included in a patent specificatio
• 【題組】 ⑶在檢定水準α = 0.05 下，此線性迴歸模型是顯著的嗎？（須說明理由）（10 分）
• 14 A license under which the licensor grants the right to use a patent to licensee under the conditi